JP2021523733A5 - - Google Patents

Info

Publication number
JP2021523733A5
JP2021523733A5 JP2021506378A JP2021506378A JP2021523733A5 JP 2021523733 A5 JP2021523733 A5 JP 2021523733A5 JP 2021506378 A JP2021506378 A JP 2021506378A JP 2021506378 A JP2021506378 A JP 2021506378A JP 2021523733 A5 JP2021523733 A5 JP 2021523733A5
Authority
JP
Japan
Prior art keywords
sequence
gene
terminus
nbd
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021506378A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021523733A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/028174 external-priority patent/WO2019204643A2/en
Publication of JP2021523733A publication Critical patent/JP2021523733A/ja
Publication of JP2021523733A5 publication Critical patent/JP2021523733A5/ja
Priority to JP2024198757A priority Critical patent/JP2025037883A/ja
Pending legal-status Critical Current

Links

JP2021506378A 2018-04-18 2019-04-18 動物病原体由来ポリペプチドおよびその遺伝子工学的利用 Pending JP2021523733A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024198757A JP2025037883A (ja) 2018-04-18 2024-11-14 動物病原体由来ポリペプチドおよびその遺伝子工学的利用

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201862659656P 2018-04-18 2018-04-18
US62/659,656 2018-04-18
US201862690905P 2018-06-27 2018-06-27
US62/690,905 2018-06-27
US201862716223P 2018-08-08 2018-08-08
US62/716,223 2018-08-08
US201862738825P 2018-09-28 2018-09-28
US62/738,825 2018-09-28
US201962819237P 2019-03-15 2019-03-15
US62/819,237 2019-03-15
PCT/US2019/028174 WO2019204643A2 (en) 2018-04-18 2019-04-18 Animal pathogen-derived polypeptides and uses thereof for genetic engineering

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024198757A Division JP2025037883A (ja) 2018-04-18 2024-11-14 動物病原体由来ポリペプチドおよびその遺伝子工学的利用

Publications (2)

Publication Number Publication Date
JP2021523733A JP2021523733A (ja) 2021-09-09
JP2021523733A5 true JP2021523733A5 (https=) 2022-04-20

Family

ID=68240638

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021506378A Pending JP2021523733A (ja) 2018-04-18 2019-04-18 動物病原体由来ポリペプチドおよびその遺伝子工学的利用
JP2024198757A Pending JP2025037883A (ja) 2018-04-18 2024-11-14 動物病原体由来ポリペプチドおよびその遺伝子工学的利用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024198757A Pending JP2025037883A (ja) 2018-04-18 2024-11-14 動物病原体由来ポリペプチドおよびその遺伝子工学的利用

Country Status (6)

Country Link
US (2) US12312383B2 (https=)
EP (1) EP3781193A4 (https=)
JP (2) JP2021523733A (https=)
AU (1) AU2019256517B2 (https=)
CA (1) CA3097648A1 (https=)
WO (1) WO2019204643A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4010004A4 (en) * 2019-08-07 2023-09-13 Altius Institute For Biomedical Sciences Compositions and methods for modulation of gene expression
JP7507242B2 (ja) * 2020-08-25 2024-06-27 中興通訊股▲ふん▼有限公司 無線ネットワーク一時識別子に関連する方法および装置
KR20230118887A (ko) 2020-12-03 2023-08-14 센츄리 쎄라퓨틱스 인코포레이티드 유전자 조작 세포 및 이의 용도
US11661459B2 (en) 2020-12-03 2023-05-30 Century Therapeutics, Inc. Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
AR124414A1 (es) 2020-12-18 2023-03-22 Century Therapeutics Inc Sistema de receptor de antígeno quimérico con especificidad de receptor adaptable
WO2025034754A2 (en) * 2023-08-08 2025-02-13 Altius Institute For Biomedical Sciences Nucleic acid binding domains and methods of use thereof

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1332209B1 (en) 2000-09-08 2009-11-11 Universität Zürich Collections of repeat proteins comprising repeat modules
US20110239315A1 (en) 2009-01-12 2011-09-29 Ulla Bonas Modular dna-binding domains and methods of use
EP2206723A1 (en) 2009-01-12 2010-07-14 Bonas, Ulla Modular DNA-binding domains
CA2769262C (en) 2009-07-28 2019-04-30 Sangamo Biosciences, Inc. Methods and compositions for treating trinucleotide repeat disorders
US8586526B2 (en) 2010-05-17 2013-11-19 Sangamo Biosciences, Inc. DNA-binding proteins and uses thereof
WO2011072246A2 (en) 2009-12-10 2011-06-16 Regents Of The University Of Minnesota Tal effector-mediated dna modification
EP2660318A1 (en) 2010-02-09 2013-11-06 Sangamo BioSciences, Inc. Targeted genomic modification with partially single-stranded donor molecules
US9499592B2 (en) 2011-01-26 2016-11-22 President And Fellows Of Harvard College Transcription activator-like effectors
US9410134B2 (en) 2011-06-07 2016-08-09 Helmholtz Zentrum München—Deutsches Forschungszentrum für Gesundheit und Umwelt Protein having nuclease activity, fusion proteins and uses thereof
JP6214530B2 (ja) 2011-07-15 2017-10-18 ザ ジェネラル ホスピタル コーポレイション 転写活性化因子様エフェクターの組立て方法
WO2013015220A1 (ja) 2011-07-22 2013-01-31 株式会社東芝 X線診断装置及び制御プログラム
CA2848417C (en) 2011-09-21 2023-05-02 Sangamo Biosciences, Inc. Methods and compositions for regulation of transgene expression
HK1200871A1 (en) 2011-11-16 2015-08-14 Sangamo Therapeutics, Inc. Modified dna-binding proteins and uses thereof
US8450107B1 (en) 2011-11-30 2013-05-28 The Broad Institute Inc. Nucleotide-specific recognition sequences for designer TAL effectors
DK2825190T3 (en) 2012-03-15 2017-02-27 Cellectis REPEAT VARIABLE DIRESTS FOR TARGETING NUCLEOTIDES
WO2013152220A2 (en) * 2012-04-04 2013-10-10 Life Technologies Corporation Tal-effector assembly platform, customized services, kits and assays
EP2877488B1 (en) * 2012-07-24 2021-02-24 Cellectis New modular base-specific nucleic acid binding domains from burkholderia rhizoxinica proteins
KR102357105B1 (ko) 2012-09-04 2022-02-08 더 스크립스 리서치 인스티튜트 표적화된 바인딩 특이도를 갖는 키메라 폴리펩타이드들
US9181535B2 (en) 2012-09-24 2015-11-10 The Chinese University Of Hong Kong Transcription activator-like effector nucleases (TALENs)
KR102121086B1 (ko) 2012-11-01 2020-06-09 팩터 바이오사이언스 인크. 세포에서 단백질을 발현시키는 방법들과 생성물들
CA2891510C (en) 2012-11-16 2022-10-18 Transposagen Biopharmaceuticals, Inc. Site-specific enzymes and methods of use
US9708589B2 (en) 2012-12-18 2017-07-18 Monsanto Technology Llc Compositions and methods for custom site-specific DNA recombinases
EP2951295B1 (en) 2013-02-01 2018-08-01 Cellectis Tevi chimeric endonucleases and their preferential cleavage sites
CA2927965A1 (en) 2013-10-25 2015-04-30 Cellectis Design of rare-cutting endonucleases for efficient and specific targeting dna sequences comprising highly repetitive motives
US9850497B2 (en) 2013-11-04 2017-12-26 Regents Of The University Of Minnesota Gene targeting methods and tools
WO2015164748A1 (en) 2014-04-24 2015-10-29 Sangamo Biosciences, Inc. Engineered transcription activator like effector (tale) proteins
WO2017019895A1 (en) 2015-07-30 2017-02-02 President And Fellows Of Harvard College Evolution of talens
US20190234874A1 (en) 2016-07-19 2019-08-01 Altius Institute For Biomedical Sciences Methods for fluorescence imaging microscopy
WO2018035387A1 (en) 2016-08-17 2018-02-22 The Broad Institute, Inc. Novel crispr enzymes and systems
KR102455249B1 (ko) 2016-08-24 2022-10-17 상가모 테라퓨틱스, 인코포레이티드 가공된 표적 특이적 뉴클레아제
EP3583203B1 (en) 2017-02-15 2023-11-01 2seventy bio, Inc. Donor repair templates multiplex genome editing
US12264181B2 (en) 2018-06-27 2025-04-01 Altius Institute For Biomedical Sciences Nucleic acid binding domains and methods of use thereof
US12209259B2 (en) 2018-06-27 2025-01-28 Altius Institute For Biomedical Sciences Nucleases for genome editing

Similar Documents

Publication Publication Date Title
JP2021523733A5 (https=)
EP3747999B1 (en) Dna modifying fusion proteins and methods of use thereof
KR100659922B1 (ko) Gnn에 대한 아연 핑거 결합 도메인
CN105960413B (zh) 人工dna-结合蛋白及其用途
JP2022115876A5 (https=)
KR20220009980A (ko) 조절된 합성 유전자 발현 시스템
US20250289853A1 (en) Nucleic acid binding domains and methods of use thereof
CA2902975C (en) Thymidine kinase diagnostic assay for gene therapy applications
US20130053544A1 (en) Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds
JP2021520212A (ja) ペプチド−mhc compact
JP2006526999A (ja) 伝達可能なdna−結合タンパク質
PT2005185E (pt) Métodos para a identificação de alvos polipeptídicos
JP7332622B2 (ja) ハンチンチン(htt)の調節のためのジンクフィンガータンパク質組成物
JP2025037883A (ja) 動物病原体由来ポリペプチドおよびその遺伝子工学的利用
WO1996006110A1 (en) Composite dna-binding proteins and materials and methods relating thereto
JP2005505233A (ja) モジュラートランスフェクション系
Alves et al. Characterization of the nuclear localization signal of the hepatitis delta virus antigen
US20030138908A1 (en) Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
WO2020025724A1 (en) Multimerizing polypeptides derived from jelly roll fold domain of adenovirus penton base
CN105999227B (zh) FOXM1蛋白氮端(1-234 aa)的表达及其用途
CN115397513A (zh) 改进的抗衰老化合物及其用途
Caradonna et al. The Nature of Enzymes Involved in Uracil-DNA Repair: Isoform Charac-teristics of Proteins Responsible for Nuclear and Mitochondrial Genomic Integrity 1
Pronk et al. Adenovirus DNA replication: the function of the covalently bound terminal protein
US20250145973A1 (en) Conditioned dna modifying enzyme comprising heterologous dna binding domain
KR101876504B1 (ko) 듀얼 리포터 유전자 동시 발현 재조합 벡터